Fuzhen Qi
Huai'an, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Biomarker-driven immunotherapy and adoptive cell therapy in recurrent pancreatic ductal adenocarcinoma.
Journal: Frontiers in medicine
Published: June 05, 2026
Prognostic significance of the preoperative lactate dehydrogenase-to-albumin ratio in patients undergoing radical resection for hilar cholangiocarcinoma.
Journal: Frontiers in medicine
Published: September 14, 2025
Comparison of clinical outcomes and prognosis between total pancreatectomy and pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: a systematic review and meta-analysis.
Journal: ANZ journal of surgery
Published: June 15, 2023
Loss of PR55α promotes proliferation and metastasis by activating MAPK/AKT signaling in hepatocellular carcinoma.
Journal: Cancer cell international
Published: December 29, 2020
Overexpression of long noncoding RNA CUDR promotes hepatic differentiation of human umbilical cord mesenchymal stem cells.
Journal: Molecular medicine reports
Published: June 01, 2019
Overexpression of OCT4 contributes to progression of hepatocellular carcinoma.
Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Published: September 13, 2015
A genetic variant at KIF1B predicts clinical outcome of HBV-related hepatocellular carcinoma in Chinese.
Journal: Cancer epidemiology
Published: April 29, 2014
A genetic variant in pseudogene E2F3P1 contributes to prognosis of hepatocellular carcinoma.
Journal: Journal of biomedical research
Published: March 16, 2014
A genetic variant in the promoter region of miR-106b-25 cluster predict clinical outcome of HBV-related hepatocellular carcinoma in Chinese.
Journal: PloS one
Published: October 29, 2013
Showing 1-11 of 11
Last Updated: 09/26/2026